Bristol-Myers Squibb Medical Imaging

At Bristol-Myers Squibb, our mission is to extend and enhance human life by Providing the hightest-quality pharmaceuticals and health care products.

345 Park Avenue
New York
NY
10154-0037
USA
Phone: 
212-546-4000
http://www.bms.com
Product Categories: Taxo=pharmaceuticals&Taxo=diagnostic_and_interventional_cardiology_daic

Related Articles

Antiplatelet Therapy

Apixaban Demonstrates Consistent Reductions in Stroke, Embolism, Major Bleeding and Mortality Compared to Warfarin
FDA Receives Resubmission of the Apixaban Drug Application to Reduce Stroke in Patients With Atrial Fibrillation
Non-Adherence to Antiplatelet Therapy Following PCI Results in More Ischemic, Bleeding Events

Atrial Fibrillation Therapies

Apixaban Demonstrates Consistent Reductions in Stroke, Embolism, Major Bleeding and Mortality Compared to Warfarin
FDA Receives Resubmission of the Apixaban Drug Application to Reduce Stroke in Patients With Atrial Fibrillation

Pharmaceuticals

Apixaban Demonstrates Consistent Reductions in Stroke, Embolism, Major Bleeding and Mortality Compared to Warfarin
FDA Receives Resubmission of the Apixaban Drug Application to Reduce Stroke in Patients With Atrial Fibrillation
FDA Announces New Boxed Warning on Plavix

FDA Announces New Boxed Warning on Plavix

Ticagrelor Shows Lower Mortality Than Clopidogrel After CABG
Big Pharma Struggles to Benefit From Increased Cardiac Drug Use
FDA Clears Effient, May be Serious Competitor to Plavix
Large Study Shows Mixed Results of Intensified PLAVIX Dose
Bristol-Myers Squibb, Pfizer Jointly Investigate New Anticoagulant
Groundbreaking Ceremony for BMS Biologics Facility

Clinical Trial/Study

Non-Adherence to Antiplatelet Therapy Following PCI Results in More Ischemic, Bleeding Events
Large Study Shows Mixed Results of Intensified PLAVIX Dose

Cath Lab

Non-Adherence to Antiplatelet Therapy Following PCI Results in More Ischemic, Bleeding Events
Ticagrelor Shows Lower Mortality Than Clopidogrel After CABG
FDA Clears Effient, May be Serious Competitor to Plavix

Cardiovascular Surgery

Non-Adherence to Antiplatelet Therapy Following PCI Results in More Ischemic, Bleeding Events
Ticagrelor Shows Lower Mortality Than Clopidogrel After CABG

Patient Safety

FDA Announces New Boxed Warning on Plavix

FDA Announces New Boxed Warning on Plavix


Hypertension Therapies

Big Pharma Struggles to Benefit From Increased Cardiac Drug Use

Contrast Media

Bristol-Myers Squibb Medical Imaging Renamed Lantheus Medical Imaging
Avista Seals Acquisition Deal with Bristol-Myers Squibb Medical Imaging
Bristol-Myers Squibb to Sell Imaging Unit for $525 Million
Bristol-Myers Squibb to Divest Medical Imaging Unit